Our company
Cygnus Pharmaceutical group was incorporated in Bulgaria in 2017, initially operating in active pharmaceutical ingredients and selected pharmaceutical raw materials. In 2019, the company launched its own branded line of finished products. The current portfolio covers injectable hormonal preparations, synthetic peptide compounds and selected oral formulations, with API-related activity maintained for professional distribution partners.Mission Cygnus Pharmaceutical group supplies finished pharmaceutical products and APIs to professional partners with the documentation, traceability and product consistency that structured pharmaceutical supply chains require. Each product in the portfolio is supported by analytical certification, product information materials and a unit-level authentication system built into every item supplied.
Approach Product selection is driven by market demand and direct partner input. Development and quality review are supported by independent third-party analytical testing, results of which are accessible through official company channels. A unit-level verification system allows distributors and end users to confirm product authenticity. The company maintains complete product documentation across its portfolio and operates through a defined network of distribution partners.
Welcome to Cygnus Pharmaceutical group
Cygnus Pharmaceutical group continues to develop its product portfolio based on market demand, partner feedback and internal product development priorities.
The company focuses on injectable and oral finished products, with API-related business activity maintained for professional partners and distribution channels.
6
Distribution partners
45
Products in portfolio